| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NCK
|
14.89 | 1.3B | 4.21 | 4.55 | 2.94 | 16.2% | 10.7% | 82 | 71 | 32.28 | +87.6% | 68 | 1.25 |
|
PMV
|
11.55 | 1.8B | 3.19 | 1.81 | 2.16 | 10.0% | 11.6% | 79 | 41 | 24.30 | +79.5% | 84 | 0.24 |
|
SUL
|
13.45 | 3.0B | 3.69 | 2.34 | 2.40 | 10.5% | 10.0% | 79 | 65 | 32.89 | +108.4% | 61 | 1.02 |
|
UNI
|
8.21 | 629.9M | 8.64 | 3.91 | 2.39 | 20.5% | 12.9% | 78 | 73 | 15.17 | +63.6% | 71 | 0.50 |
|
LOV
|
25.72 | 2.8B | 8.11 | 26.35 | 3.61 | 22.9% | 11.3% | 71 | 74 | 39.16 | +37.6% | 56 | 4.45 |
|
ASG
|
1.47 | 313.2M | 9.53 | 0.62 | 8.71 | 2.2% | 7.5% | 57 | 59 | 2.80 | +65.3% | 34 | 2.20 |
|
MYR
|
0.20 | 346.1M | — | 0.37 | — | -3.9% | 6.0% | 50 | 43 | 0.60 | +85.0% | 32 | 1.66 |
|
APE
|
21.36 | 6.0B | 26.59 | 3.25 | 12.33 | 12.2% | 9.6% | 46 | 48 | 15.56 | -18.2% | 53 | 1.65 |
|
COL
|
24.04 | 32.3B | 29.62 | 8.18 | 12.56 | 12.6% | 9.2% | 43 | 43 | 14.22 | -27.4% | 53 | 2.51 |
|
TPW
|
4.81 | 560.0M | 32.53 | 4.18 | 12.00 | 11.7% | 13.3% | 43 | 44 | 2.92 | -29.3% | 80 | 0.32 |
|
DDR
|
14.64 | 2.7B | 31.06 | 10.34 | 18.83 | 21.9% | 11.6% | 41 | 34 | 5.46 | -47.0% | 71 | 1.45 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.